#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Internal Medicine - Issue 3/2021

Review Articles

138

Don't we forget about biological therapy of hypercholesterolemia with PCSK9-inhibitors?

Vladimír Soška, Ondřej Kyselák

143

What's new in the 2020 update of the CEAP classification system of chronic venous disease?

Dalibor Musil

150

Treatment strategies for myelodysplastic syndrome in 2021

Petra Bělohlávková

157

Therapy of 3 patients with Erdhiem-Chester disease with cladribin or cladribin in combination with cyclophosphamide. Case report and review of the therapy

Zdeněk Král, Zdeněk Řehák, Marta Krejčí, Renata Koukalová, Sabina Ševčíková, Luděk Pour, Martin Krejčí, Martin Štork, Viera Sandecká, Zdeněk Adam

165

Rivaroxaban for the treatment and prevention of reccurence of venous thromboembolism in children

Eliška Boženková, Miroslav Souček

170

The use of moxonidine in the treatment of arterial hypertension

Jan Vachek

Case reports

175

Pembrolizumab-induced hypothyreosis and subcutaneous bleeding

Pavel Polák, Jana Špeldová, Monika Bratová, Jiřina Zavřelová, Miroslav Penka

180

Vericiguat in patients with heart failure and reduced ejection fraction

Jindřich Špinar, Lenka Špinarová, Jiří Vítovec

184

Komentáře k analýze složení směsi flavonoidů v tabletách Diozen 500 mg metodou UHPLC

František Kováčik, Anna Šantorová

Internal Medicine

Issue 3

2021 Issue 3

Most read in this issue

#ADS_BOTTOM_SCRIPTS#